By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlobeImmune, Inc. 

1450 Infinite Drive

Louisville  Colorado  80027  U.S.A.
Phone: 303-625-2700 Fax: 303-625-2710


Company News
GlobeImmune, Inc. (GBIM) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 12:17:01 PM
GlobeImmune, Inc. (GBIM) Announces Third Quarter 2014 Financial Results 11/12/2014 2:11:56 PM
GlobeImmune, Inc. (GBIM) Release: Updated Chordoma Data From Phase 1 Study Of GI-6301 Presented At 2014 Connective Tissue Oncology Society (CTOS) Annual Meeting 10/17/2014 9:28:39 AM
GlobeImmune, Inc. (GBIM) To Present At The 13th Annual BioInvestor Forum 9/30/2014 1:12:27 PM
GlobeImmune, Inc. (GBIM) To Present At The 21st Annual NewsMakers In The Biotechnology Industry Investment Conference 9/18/2014 1:40:53 PM
GlobeImmune, Inc. (GBIM) To Present At The Aegis Capital Corp. 2014 Healthcare Conference 9/3/2014 12:20:40 PM
GlobeImmune, Inc. (GBIM) Announces Second Quarter 2014 Financial Results 8/18/2014 9:12:19 AM
GlobeImmune, Inc. (GBIM) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriter's Overallotment Option 7/9/2014 9:05:06 AM
Colorado's GlobeImmune, Inc. (GBIM) Prices IPO At $10 A Share, Below Expectations 7/2/2014 6:07:32 AM
Louisville's GlobeImmune, Inc. Reduces Size Of Proposed IPO 5/22/2014 7:51:38 AM